Evidence map›Paper›PMID 30546249›Full record

ArticleThe Egyptian journal of neurology, psychiatry and neurosurgery2018

Sympathetic skin response in patients with systemic sclerosis and rheumatoid arthritis.

Reda Badry, Rania M Gamal, Manal M Hassanien, Mohamed Abd El Hamed, Nevin Hammam, Bastawy M El Fawal

Abstract read
In one paragraph

Article in The Egyptian journal of neurology, psychiatry and neurosurgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Reda Badry1Department of Neurology and Psychiatry, Assiut University Hospital, Post Box: 711526, Assiut, Egypt.
Rania M Gamal2Rheumatology and Rehabilitation Department, Assiut University Hospital, Assiut, Egypt.
Manal M Hassanien2Rheumatology and Rehabilitation Department, Assiut University Hospital, Assiut, Egypt.
Mohamed Abd El Hamed1Department of Neurology and Psychiatry, Assiut University Hospital, Post Box: 711526, Assiut, Egypt.
Nevin Hammam2Rheumatology and Rehabilitation Department, Assiut University Hospital, Assiut, Egypt.
Bastawy M El Fawal3Department of Neurology and Psychiatry, Aswan University Hospital, Aswan, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSympathetic skin response (SSR) is a technique to assess the sympathetic cholinergic pathways. Sympathetic dysfunction may participate in the development of pain, which is the major complaint in patients with systemic sclerosis (SSc) and rheumatoid arthritis (RA).

objectivesIn this study, we aimed to assess the autonomic dysfunction in patients with (SSc) and (RA) using SSR as a simple neurophysiologic test.

methodsPalmar SSR to median nerve electrical stimulation was recorded in 21 patients with SSc, 39 patients with RA, and in 60 healthy age and sex-matched control subjects.

resultsPalmar SSR to median nerve stimulation (of SSc patients and RA patients) shows significantly delayed latency and reduced amplitude in comparison to the control group. SSR of SSc patients has significantly delayed latency and reduced amplitude when compared to RA patients. Moreover, six SSc patients have delayed SSR in spite of the absence of manifestations of polyneuropathy.

conclusionsPatients with SSc and RA have features of autonomic dysfunction with more affection of SSc patients.

Indexed as

Autonomic dysfunction (AD)Rheumatoid arthritis (RA)Sympathetic skin response (SSR)Systemic sclerosis (SSc)

Identifiers

PMID30546249
PMCPMC6267634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.